Biosceptre wins Gold Medal at China’s largest event for promoting innovation and entrepreneurship
Upon invitation from our lead investor Tuspark S&T, Biosceptre recently [...]
Upon invitation from our lead investor Tuspark S&T, Biosceptre recently [...]
Biosceptres' Phase I clinical trial for peptide vaccine BIL06v has [...]
Biosceptre congratulates the chair of our Science Advisory Board and [...]